Brasilia, Jan 6 (Prensa Latina) Brazil will receive from China the first batch of the Active Pharmaceutical Ingredient (API) for the production of the anti-Covid-19 vaccine developed by the University of Oxford (UK) and the Anglo-Swedish company AstraZeneca.